全文获取类型
收费全文 | 4801篇 |
免费 | 231篇 |
国内免费 | 20篇 |
专业分类
耳鼻咽喉 | 51篇 |
儿科学 | 88篇 |
妇产科学 | 18篇 |
基础医学 | 451篇 |
口腔科学 | 78篇 |
临床医学 | 293篇 |
内科学 | 1366篇 |
皮肤病学 | 236篇 |
神经病学 | 253篇 |
特种医学 | 135篇 |
外科学 | 919篇 |
综合类 | 28篇 |
预防医学 | 121篇 |
眼科学 | 64篇 |
药学 | 309篇 |
中国医学 | 4篇 |
肿瘤学 | 638篇 |
出版年
2023年 | 25篇 |
2022年 | 68篇 |
2021年 | 99篇 |
2020年 | 51篇 |
2019年 | 75篇 |
2018年 | 65篇 |
2017年 | 56篇 |
2016年 | 81篇 |
2015年 | 93篇 |
2014年 | 86篇 |
2013年 | 117篇 |
2012年 | 215篇 |
2011年 | 206篇 |
2010年 | 115篇 |
2009年 | 119篇 |
2008年 | 185篇 |
2007年 | 166篇 |
2006年 | 190篇 |
2005年 | 191篇 |
2004年 | 205篇 |
2003年 | 205篇 |
2002年 | 203篇 |
2001年 | 186篇 |
2000年 | 211篇 |
1999年 | 158篇 |
1998年 | 75篇 |
1997年 | 63篇 |
1996年 | 50篇 |
1995年 | 56篇 |
1994年 | 60篇 |
1993年 | 43篇 |
1992年 | 102篇 |
1991年 | 109篇 |
1990年 | 95篇 |
1989年 | 110篇 |
1988年 | 99篇 |
1987年 | 85篇 |
1986年 | 113篇 |
1985年 | 87篇 |
1984年 | 51篇 |
1983年 | 58篇 |
1982年 | 31篇 |
1979年 | 39篇 |
1978年 | 22篇 |
1977年 | 44篇 |
1975年 | 27篇 |
1972年 | 29篇 |
1971年 | 30篇 |
1970年 | 32篇 |
1969年 | 21篇 |
排序方式: 共有5052条查询结果,搜索用时 15 毫秒
71.
Takaaki Imamura Osamu Yokosuka Tetsuhiro Chiba Tatso Kanda Hiroshige Kojima Kenichi Fukai Fumio Imazeki Miki Nishimura Yasushi Saito Hiromitsu Saisho 《Leukemia & lymphoma》2005,46(6):915-917
We report the case of a 52-year-old woman with hepatitis B virus (HBV) reactivation during treatment for chronic graft vs. host disease (GVHD) after peripheral bone marrow transplantation (PBSCT) to treat chronic myelocytic leukemia. She was given cyclosporine and prednisolone orally to treat chronic GVHD after PBSCT. Liver dysfunction first developed 25 months after transplantation with the appearance of hepatitis B s antigen (HBsAg), hepatitis B e antigen (HBeAg), and elevation of HBV-DNA up to 4.5 log copies/ml. Retrospective examination of her serum before PBSCT proved negative for HBsAg and HBeAg, and positive for anti-HBsAg, anti-HBeAg, anti-hepatitis B core antigen, and HBV-DNA (2.7 log copies/ml), showing that she was in a state of occult HBV infection. Nucleotide sequences of the HBV genome obtained from her serum showed no core promoter mutations at nt 1762 and 1764 and no pre-core mutation at nt 1896. Polymerase chain reaction-restriction fragment length polymorphism showed that she was infected with HBV genotype B. The administration of lamivudine, a nucleoside analog, improved her liver function and reduced HBV-DNA replication. We conclude that antiviral agents, such as lamivudine, are effective for treating hepatitis B reactivation during immunosuppressive treatment, such as for GVHD. The administration of a nucleoside analog before transplantation should also be considered in the light of HBV genotypes and mutations, even if HBsAg was negative and the viral load was low before transplantation. 相似文献
72.
Transcriptional down-regulation of the rearranged C-myc expression in murine cell hybrids between a plasmacytoma and a T-cell lymphoma 总被引:1,自引:0,他引:1
73.
Shiga T Nagata K Akagi K Shiraishi T Imamura M Tanaka Y 《International journal of oncology》1997,11(6):1279-1285
Superficial, subsurface tumors of 93 patients were treated with thermoradiotherapy using a 430 MHz microwave heating system (HTS-100). All patients had malignant tumors, and all were treated with a combination of hyperthermia and radiation. Satisfactory temperature data for each thermal parameter were achieved within a 5 cm depth for each tumor. The overall complete response (CR) rate was 39.8%; in the less than or equal to 3 cm (depth of tumor), the CR rate was 66.7%, in the 3-5 cm group, the CR rate was 42.9%. In the multivariate analysis, duration of local control correlated with tumor responses (CR). There were no instances of prominent late complications that were observed for greater than or equal to 6 months. This study suggests that the HTS-100 may improve tumor response and the duration of local control of superficial and subsurface tumors. 相似文献
74.
CXCL12/CXCR4 activation by cancer‐associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer
下载免费PDF全文
![点击此处可从《International journal of cancer. Journal international du cancer》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Daisuke Izumi Takatsugu Ishimoto Keisuke Miyake Hidetaka Sugihara Kojiro Eto Hiroshi Sawayama Tadahito Yasuda Yuki Kiyozumi Takayoshi Kaida Junji Kurashige Yu Imamura Yukiharu Hiyoshi Masaaki Iwatsuki Shiro Iwagami Yoshifumi Baba Yasuo Sakamoto Yuji Miyamoto Naoya Yoshida Masayuki Watanabe Hiroshi Takamori Norie Araki Patrick Tan Hideo Baba 《International journal of cancer. Journal international du cancer》2016,138(5):1207-1219
Cancer‐associated fibroblasts (CAFs) are reportedly involved in invasion and metastasis in several types of cancer, including gastric cancer (GC), through the stimulation of CXCL12/CXCR4 signaling. However, the mechanisms underlying these tumor‐promoting effects are not well understood, which limits the potential to develop therapeutic targets against CAF‐mediated CXCL12/CXCR4 signaling. CXCL12 expression was analyzed in resected GC tissues from 110 patients by immunohistochemistry (IHC). We established primary cultures of normal fibroblasts (NFs) and CAFs from the GC tissues and examined the functional differences between these primary fibroblasts using co‐culture assays with GC cell lines. We evaluated the efficacy of a CXCR4 antagonist (AMD3100) and a FAK inhibitor (PF‐573,228) on the invasive ability of GC cells. High CXCL12 expression levels were significantly associated with larger tumor size, increased tumor depth, lymphatic invasion and poor prognosis in GC. CXCL12/CXCR4 activation by CAFs mediated integrin β1 clustering at the cell surface and promoted the invasive ability of GC cells. Notably, AMD3100 was more efficient than PF‐573,228 at inhibiting GC cell invasion through the suppression of integrin β1/FAK signaling. These results suggest that CXCL12 derived from CAFs promotes GC cell invasion by enhancing the clustering of integrin β1 in GC cells, resulting in GC progression. Taken together, the inhibition of CXCL12/CXCR4 signaling in GC cells may be a promising therapeutic strategy against GC cell invasion. 相似文献
75.
Makiko Nakamura Teruhiko Imamura Takuya Fukui Naoya Kataoka Koichiro Kinugawa 《Internal medicine (Tokyo, Japan)》2022,61(20):3063
Patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) classically present with ventricular arrhythmias and less commonly heart failure. ARVC is an inherited cardiomyopathy and generally based on a variant of desmosomal genes. Recently, the association between myocardial inflammation and ARVC has been a matter of great concern. We encountered a patient with ARVC who had a desmoglein-2 mutation with advanced right ventricular failure accompanying a preserved left ventricular function. Concomitant right ventricular myocarditis was detected four years after the diagnosis of ARVC. ARVC and myocarditis might have a deep pathophysiological association, at least in some cases. 相似文献
76.
Teruhiko Imamura Toshihide Izumida Masakazu Hori Shuhei Tanaka Koichiro Kinugawa 《The Journal of international medical research》2022,50(7)
Cardiac amyloidosis usually presents with diastolic dysfunction, but sometimes systolic dysfunction develops, particularly at its advanced stage. However, the therapeutic strategy for patients with cardiac amyloidosis and systolic dysfunction remains unknown. We report a 77-year-old man who was diagnosed with wild-type cardiac amyloidosis and systolic dysfunction with a left ventricular ejection fraction of 27%. Following 6-month medical therapy of tafamidis 80 mg and neurohormonal blockers (carvedilol 5.0 mg, enalapril 2.5 mg, and spironolactone 25 mg), the left ventricular ejection fraction improved to 55%. Tafamidis-incorporated neurohormonal blocker therapy might be a promising strategy to facilitate cardiac reverse remodeling in patients with cardiac amyloidosis and systolic dysfunction. 相似文献
77.
78.
Daisuke Tamanoi Koichi Saruwatari Kosuke Imamura Ryo Sato Takuya Jodai Shohei Hamada Yusuke Tomita Sho Saeki Shikiko Ueno Yuji Yonemura Hidenori Ichiyasu Takuro Sakagami 《Internal medicine (Tokyo, Japan)》2022,61(11):1731
The effect of radiotherapy during immunotherapy on immune-related adverse events (irAEs) is not fully understood. We herein report a 74-year-old woman diagnosed with lung adenocarcinoma with programmed death ligand 1 expression ≥50% and treated with pembrolizumab. She developed fatal immune thrombocytopenia associated with pembrolizumab immediately following radiotherapy. A flow cytometry analysis of peripheral blood detected an increased expression of programmed death-1 (PD-1) and Ki-67 in CD4+ and CD8+ T cells after radiotherapy, compared with pre-irradiation measurements. This case suggests that radiotherapy may evoke irAEs during treatment with anti-PD-1 antibodies, which physicians should consider when using radiotherapy in patients treated with these drugs. 相似文献
79.